COA Certified · Every Batch TestedSame-Day Shipping on Orders by 2PM ESTUSA Sourced · USA ShippedFree Shipping on Orders Over $300≥99% Purity — HPLC + Mass SpecEndotoxin Tested · Sterility VerifiedCOA Certified · Every Batch TestedSame-Day Shipping on Orders by 2PM ESTUSA Sourced · USA ShippedFree Shipping on Orders Over $300≥99% Purity — HPLC + Mass SpecEndotoxin Tested · Sterility Verified
For Laboratory & Research Use Only — Not for Human or Veterinary Use
All ProductsGLP-1 & MetabolicResearch PeptidesPeptide BlendsNasal SpraysDissolving StripsBioregulatorsResearch BundlesLab Supplies Search
Research Compound Reference

Tesamorelin + Ipamorelin

This blend pairs tesamorelin at 10 mg with ipamorelin at 5 mg, co-lyophilized into a single vial labeled at 15 mg total peptide content. The two components engage different receptors within the same endocrine axis in the published literature, which is why they are studied together.

Molecular profile of Tesamorelin + Ipamorelin
Also known asTesamorelin / Ipamorelin blend
CAS NumberTesamorelin: 218949-48-5 Ipamorelin: 170851-70-4
Molecular FormulaTesamorelin: C221H366N72O67S Ipamorelin: C38H49N9O5
Molecular WeightTesamorelin: 5135.86 Ipamorelin: 711.85
Amino Acid CountTesamorelin: 44 Ipamorelin: 5
SequenceTesamorelin: 44-residue GHRH analogue, trans-3-hexenoyl-modified (per COA) Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Purity≥99% by HPLC · COA available
Physical FormLyophilized powder

What is Tesamorelin + Ipamorelin?

Tesamorelin is a growth-hormone-releasing factor analogue, CAS 218949-48-5, formula C221H366N72O67S, molecular weight 5135.9, built on the GRF(1-44) scaffold. Ipamorelin is a growth-hormone secretagogue, CAS 170851-70-4, formula C38H49N9O5, molecular weight 711.85, sequence H-Aib-His-D-2-Nal-D-Phe-Lys-NH2. That sequence carries three non-standard features, an alpha-aminoisobutyric acid at the N-terminus, two D-configured aromatic residues, and a C-terminal amide, all of which slow enzymatic breakdown relative to an all-L linear peptide.

The pairing follows a logic well described in endocrine pharmacology. GHRH analogues engage the GHRH receptor on somatotroph cells, while secretagogues of the ipamorelin type act at the growth hormone secretagogue receptor through a separate signaling route. In rodent and cell studies the two classes produce responses described as additive rather than redundant, and ipamorelin is characterized as comparatively selective relative to earlier secretagogues.

What is not settled is how this fixed ratio compares with the two peptides assayed separately, since no controlled study of the co-lyophilized preparation has been published. The relative contribution of each receptor pathway also varies between species and model systems, so results do not transfer cleanly between preparations.

Reconstitution & handling

Bacteriostatic or sterile water added slowly against the vial wall dissolves both components, and the cake should clear within a minute of gentle swirling. Total concentration is the labeled 15 mg divided by the diluent volume, with individual concentrations following the 10 to 5 split. The larger tesamorelin chain foams if the vial is shaken, so letting it stand is preferable. Visible haze means the vial should not be used analytically.

Storage & stability

Lyophilized vials are held at -20 degrees Celsius, protected from light and from moisture, with the cake dry and intact. After reconstitution the solution is refrigerated at 2 to 8 degrees Celsius, divided into single-use aliquots, and kept clear of repeated freeze-thaw cycles, the main practical cause of potency loss in solution. Tesamorelin is the larger and more conformationally complex component and is therefore the fraction most sensitive to thermal excursions.

How it's tested

Reverse-phase HPLC with detection at 214 and 220 nanometres separates the two components cleanly given the large mass difference, and relative peak areas are compared against the declared 10 to 5 ratio. Mass spectrometry confirms identity against theoretical average masses of 5135.9 and 711.85, with the non-standard residues of ipamorelin giving a distinctive fragmentation pattern. Net peptide content is measured so the 15 mg label reflects peptide alone.

Frequently asked questions

Why combine a GHRH analogue with a secretagogue?

Because in the published literature they engage two different receptors on the same cell population. Studies examining pathway interaction need both present in a defined ratio.

What is Aib in the ipamorelin sequence?

Alpha-aminoisobutyric acid, a non-proteinogenic residue with two methyl groups on the alpha carbon. It constrains local backbone conformation and resists aminopeptidase cleavage.

Do the two components separate on the chromatogram?

Yes. A 711 dalton pentapeptide and a 5136 dalton polypeptide elute far apart under standard reverse-phase conditions, which makes ratio verification straightforward.

Shop lot-tested Tesamorelin + Ipamorelin

Third-party tested to ≥99% purity, with analytical documentation available.

View product →Reconstitution calculator
Related compounds
BPC-157 + TB-500 (Wolverine Blend)CJC-1295 (No DAC) + GHRP-6CJC-1295 (No DAC) + IpamorelinGLOW Mix

This reference describes the compound's chemistry and analytical properties for laboratory research use only. It is not medical advice; the product is not a drug, supplement, or cosmetic and is not for human or veterinary consumption.